glycerylphosphorylcholine has been researched along with Cognition Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chul Youn, Y; Han, SH | 1 |
| Amenta, F; Sagaro, GG; Traini, E | 1 |
| Amenta, F; Bramanti, V; Traini, E | 1 |
| Pizova, NV | 1 |
| Chan, A; Shea, TB; Suchy, J | 1 |
| Anikina, MA; Batukaeva, LA; Iunishchenko, NA; Levin, OS | 1 |
| Forghieri, M; Genovese, E; Gherpelli, C; Marrara, A; Monzani, D; Panzetti, P; Presutti, L | 1 |
| Scapicchio, PL | 1 |
| Amenta, F; Mignini, F; Parnetti, L; Tomassoni, D; Traini, E | 1 |
| Amenta, F; Gallai, V; Parnetti, L | 1 |
4 review(s) available for glycerylphosphorylcholine and Cognition Disorders
| Article | Year |
|---|---|
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
Topics: Cognition; Cognition Disorders; Cognitive Dysfunction; Donepezil; Glycerylphosphorylcholine; Humans; Randomized Controlled Trials as Topic | 2023 |
Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
Topics: Animals; Brain; Cognition; Cognition Disorders; Glycerylphosphorylcholine; Humans; Phospholipids | 2013 |
Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
Topics: Animals; Cognition Disorders; Dementia; Glycerylphosphorylcholine; Humans; Nootropic Agents | 2013 |
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Topics: Acetylcholine; Animals; Brain; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Neuroprotective Agents; Nootropic Agents; Phospholipids | 2007 |
2 trial(s) available for glycerylphosphorylcholine and Cognition Disorders
| Article | Year |
|---|---|
[The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment].
Topics: Aged; Brain Ischemia; Cognition Disorders; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Neuroprotective Agents; Quality of Life; Treatment Outcome | 2014 |
[Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Treatment Outcome | 2009 |
4 other study(ies) available for glycerylphosphorylcholine and Cognition Disorders
| Article | Year |
|---|---|
Quantitative electroencephalography changes in patients with mild cognitive impairment after choline alphoscerate administration.
Topics: Biomarkers; Cognition; Cognition Disorders; Cognitive Dysfunction; Electroencephalography; Glycerylphosphorylcholine; Humans | 2022 |
Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Antioxidants; Apolipoproteins E; Cognition Disorders; Dietary Supplements; Docosahexaenoic Acids; Drug Therapy, Combination; Folic Acid Deficiency; Glycerylphosphorylcholine; Iron; Maze Learning; Mice; Mice, Knockout; Nootropic Agents; Oxidative Stress; Phosphatidylserines; Reactive Oxygen Species; Thioctic Acid; Vitamin E Deficiency | 2009 |
Stimulation of the cholinergic neurotransmissions enhances the efficacy of vestibular rehabilitation.
Topics: Aged; Aged, 80 and over; Cognition Disorders; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Retrospective Studies; Vestibular Diseases | 2010 |
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Parasympathomimetics; Periodicals as Topic; Statistics as Topic | 2001 |